DrugMonitor™ Anti-Olaratumab Antibody (VS-1224-YC837) (CAT#: VS-1224-YC837)
Olaratumab is an antibody that inhibits the platelet-derived growth factor receptor alpha, used in combination with doxorubicin for treating certain types of soft tissue sarcoma (STS). The DrugMonitor™ Anti-Olaratumab Antibody (VS-1224-YC837) is an anti-drug antibody (ADA) against Olaratumab. This drug-based antibody is raised in mice immunized with the Olaratumab. The anti-Olaratumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Olaratumab in samples.
Specific Inquiry
Specifications
- Host Animal
- Mouse
- Specificity
- Olaratumab
- Target
- Olaratumab
- Immunogen
- Olaratumab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Olaratumab
- Drug Weight
- 154000.0 Da (with glycans)
- Formula
- C₆₅₅₄H₁₀₀₇₆N₁₇₃₆O₂₀₄₈S₄₀
- Related Disease
- Certain types of soft tissue sarcoma (STS)
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Olaratumab"
Anti-Human PDGF-R alpha Recombinant Antibody (Olaratumab)Recombinant monoclonal antibody to PDGF-R alpha. Olaratumab is a monoclonal antibody which is for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.
Afuco™ Anti-PDGFRA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-192)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to PDGF-R alpha. It is a monoclonal antibody which is for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1224-YC837. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, FuncS, IF, Neut, ELISA, FC, IP
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: Neut, ELISA, Inhib, ICC, WB
-1-1.png)
Application: ELISA, FC
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: FC, IA, IF, IP, IHC, FuncS
Application: ELISA, Inhib, FC, Neut
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
